Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1983 Sep;53(3):521–528.

C1 inactivator-C1s complexes in inflammatory joint disease.

R D Inman, P C Harpel
PMCID: PMC1535655  PMID: 6604603

Abstract

A newly developed enzyme linked immunosorbent assay for the quantitation of C1 inhibitor (C1In)-C1s complexes was used to study activation of the classical pathway of complement in inflammatory joint diseases. Synovial fluid (SF) specimens were obtained from patients with rheumatoid arthritis (RA), other arthritides and non-inflammatory joint effusions. Paired serum (S) samples were obtained in 17 cases. Immune complexes (IC) were measured by the staphylococcal binding assay. C1In-C1s were higher in RA SF samples than in paired RAS samples (P less than 0.01). IC were higher in RA SF than non-RA SF. There was a significant inverse correlation between SF C1In-C1s complexes and SF total haemolytic complement. For all SF samples there was a correlation between IC and C1In-C1s complexes, but for RA SF alone there was no significant correlation between these parameters. There was no correlation between titre of rheumatoid factor and C1In-C1s complexes. These results demonstrate that activation of the classical pathway of complement is the hallmark of rheumatoid synovitis, yet also suggest functional heterogeneity of both circulating and intra-articular IC.

Full text

PDF
521

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bunch T. W., Hunder G. G., Offord K., McDuffie F. C. Synovial fluid complement: usefulness in diagnosis and classification of rheumatoid arthritis. Ann Intern Med. 1974 Jul;81(1):32–35. doi: 10.7326/0003-4819-81-1-32. [DOI] [PubMed] [Google Scholar]
  2. Chesne S., Villiers C. L., Arlaud G. J., Lacroix M. B., Colomb M. G. Fluid-phase interaction of C1 inhibitor (C1 Inh) and the subcomponents C1r and C1s of the first component of complement, C1. Biochem J. 1982 Jan 1;201(1):61–70. doi: 10.1042/bj2010061. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. De Bracco M. M., Stroud R. M., Christian C. L. Studies on the first component of complement (C1) and the inhibitor of C1 esterase in rheumatoid synovial fluids. Clin Exp Immunol. 1972 Jun;11(2):209–218. [PMC free article] [PubMed] [Google Scholar]
  4. Doekes G., Vanes L. A., Daha M. R. Influence of aggregate size on the binding and activation of the first component of human complement by soluble IgG aggregates. Immunology. 1982 Apr;45(4):705–713. [PMC free article] [PubMed] [Google Scholar]
  5. Hack C. E., Hannema A. J., Eerenberg-Belmer A. J., Out T. A., Aalberse R. C. A C1-inhibitor-complex assay (INCA): a method to detect C1 activation in vitro and in vivo. J Immunol. 1981 Oct;127(4):1450–1453. [PubMed] [Google Scholar]
  6. Halla J. T., Volanakis J. E., Hardin J. G., Schrohenloher R. E. Immune complex detection and complement activity in rheumatoid arthritis: a comparative study of a radioimmunoassay using monoclonal rheumatoid factor, gel diffusion techniques and C4 activity. Clin Exp Immunol. 1978 Nov;34(2):226–234. [PMC free article] [PubMed] [Google Scholar]
  7. Hedberg H., Lundh B., Laurell A. B. Studies of the third component of complement in synovial fluid from arthritic patients. II. Conversion and its relation to total complement. Clin Exp Immunol. 1970 May;6(5):707–712. [PMC free article] [PubMed] [Google Scholar]
  8. KENT J. F., FIFE E. H., Jr Precise standardization of reagents for complement fixation. Am J Trop Med Hyg. 1963 Jan;12:103–116. doi: 10.4269/ajtmh.1963.12.103. [DOI] [PubMed] [Google Scholar]
  9. Kaplan R. A., Curd J. G., Deheer D. H., Carson D. A., Pangburn M. K., Müller-Eberhard H. J., Vaughan J. H. Metabolism of C4 and factor B in rheumatoid arthritis. Relation to rheumatoid factor. Arthritis Rheum. 1980 Aug;23(8):911–920. doi: 10.1002/art.1780230806. [DOI] [PubMed] [Google Scholar]
  10. Kim H. J., McCarty D. J., Kozin F., Koethe S. Clinical significance of synovial fluid total hemolytic complement activity. J Rheumatol. 1980 Mar-Apr;7(2):143–152. [PubMed] [Google Scholar]
  11. Laurell A. B., Mårtensson U., Sjöholm A. G. Quantitation of Clr-Cls-Cl inactivator complexes by electroimmunoassay. Acta Pathol Microbiol Scand C. 1979 Feb;87C(1):79–81. [PubMed] [Google Scholar]
  12. McDougal J. S., Redecha P. B., Inman R. D., Christian C. L. Binding of immunoglobulin G aggregates and immune complexes in human sera to Staphylococci containing protein A. J Clin Invest. 1979 Apr;63(4):627–636. doi: 10.1172/JCI109345. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. McDuffie F. C., Hunder G. G., Clark R. J. Complement-fixing material in ther sera of patients with rheumatoid arthritis. Clin Exp Immunol. 1978 May;32(2):218–225. [PMC free article] [PubMed] [Google Scholar]
  14. PEKIN T. J., Jr, ZVAIFLER N. J. HEMOLYTIC COMPLEMENT IN SYNOVIAL FLUID. J Clin Invest. 1964 Jul;43:1372–1382. doi: 10.1172/JCI105013. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. PLOTZ C. M., SINGER J. M. The latex fixation test. I. Application to the serologic diagnosis of rheumatoid arthritis. Am J Med. 1956 Dec;21(6):888–892. [PubMed] [Google Scholar]
  16. Prystowsky M. B., Kehoe J. M., Erickson B. W. Inhibition of the classical complement pathway by synthetic peptides from the second constant domain of the heavy chain of human immunoglobulin G. Biochemistry. 1981 Oct 27;20(22):6349–6356. doi: 10.1021/bi00525a010. [DOI] [PubMed] [Google Scholar]
  17. Ruddy S., Colten H. R. Rheumatoid arthritis. Biosynthesis of complement proteins by synovial tissues. N Engl J Med. 1974 Jun 6;290(23):1284–1288. doi: 10.1056/NEJM197406062902304. [DOI] [PubMed] [Google Scholar]
  18. Sabharwal U. K., Vaughan J. H., Fong S., Bennett P. H., Carson D. A., Curd J. G. Activation of the classical pathway of complement by rheumatoid factors. Assessment by radioimmunoassay for C4. Arthritis Rheum. 1982 Feb;25(2):161–167. doi: 10.1002/art.1780250208. [DOI] [PubMed] [Google Scholar]
  19. Sheppeard H., Lea D. J., Ward D. J. Synovial fluid total hemolytic complement activity in rheumatic diseases - a reappraisal. J Rheumatol. 1981 May-Jun;8(3):390–397. [PubMed] [Google Scholar]
  20. Siegel R. C., Schumaker V. N., Poon P. H. Stoichiometry and sedimentation properties of the complex formed between the C1q and C1r2C1s2 subcomponents of the first component of complement. J Immunol. 1981 Dec;127(6):2447–2452. [PubMed] [Google Scholar]
  21. Van Schravendijk M. R., Dwek R. A. Interaction of C1q with DNA. Mol Immunol. 1982 Sep;19(9):1179–1187. doi: 10.1016/0161-5890(82)90328-5. [DOI] [PubMed] [Google Scholar]
  22. Ziccardi R. J. A new role for C-1-inhibitor in homeostasis: control of activation of the first component of human complement. J Immunol. 1982 Jun;128(6):2505–2508. [PubMed] [Google Scholar]
  23. Ziccardi R. J., Cooper N. R. Active disassembly of the first complement component, C-1, by C-1 inactivator. J Immunol. 1979 Aug;123(2):788–792. [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES